Jiangsu Nhwa Pharmaceutical Co Ltd (002262) — Financial Flexibility Index
Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has a Financial Flexibility Index of 0.50x as of September 2025. Free cash flow of CN¥506.78 Million (operating CF CN¥425.83 Million minus capex CN¥80.95 Million) represents 1% of total liabilities (CN¥1.00 Billion). Check Jiangsu Nhwa Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jiangsu Nhwa Pharmaceutical Co Ltd Financial Flexibility Index (2005–2025)
Historical Financial Flexibility Index trend for Jiangsu Nhwa Pharmaceutical Co Ltd across 21 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Jiangsu Nhwa Pharmaceutical Co Ltd.
Annual Financial Flexibility Index for Jiangsu Nhwa Pharmaceutical Co Ltd (2005–2025)
Year-by-year free cash flow to debt coverage for Jiangsu Nhwa Pharmaceutical Co Ltd. Explore Jiangsu Nhwa Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.27x | CN¥1.52 Billion | CN¥1.08 Billion | CN¥1.20 Billion | ▲ +8.3% |
| 2024 | 1.17x | CN¥1.37 Billion | CN¥916.13 Million | CN¥1.17 Billion | ▼ -22.2% |
| 2023 | 1.51x | CN¥1.38 Billion | CN¥1.01 Billion | CN¥918.09 Million | ▲ +13.7% |
| 2022 | 1.32x | CN¥1.19 Billion | CN¥861.02 Million | CN¥897.43 Million | ▲ +15.9% |
| 2021 | 1.14x | CN¥907.22 Million | CN¥701.12 Million | CN¥793.45 Million | ▼ -46.7% |
| 2020 | 2.15x | CN¥1.52 Billion | CN¥1.25 Billion | CN¥706.67 Million | ▲ +174.7% |
| 2019 | 0.78x | CN¥466.27 Million | CN¥305.97 Million | CN¥596.68 Million | ▲ +46.0% |
| 2018 | 0.54x | CN¥575.22 Million | CN¥404.52 Million | CN¥1.07 Billion | ▼ -27.3% |
| 2017 | 0.74x | CN¥618.36 Million | CN¥452.35 Million | CN¥840.24 Million | ▲ +65.1% |
| 2016 | 0.45x | CN¥379.36 Million | CN¥277.14 Million | CN¥850.97 Million | ▼ -23.4% |
| 2015 | 0.58x | CN¥420.87 Million | CN¥204.24 Million | CN¥723.60 Million | ▲ +19.1% |
| 2014 | 0.49x | CN¥421.84 Million | CN¥160.24 Million | CN¥863.61 Million | ▲ +19.7% |
| 2013 | 0.41x | CN¥297.96 Million | CN¥194.33 Million | CN¥730.13 Million | ▲ +16.4% |
| 2012 | 0.35x | CN¥232.17 Million | CN¥154.16 Million | CN¥662.41 Million | ▲ +48.0% |
| 2011 | 0.24x | CN¥127.28 Million | CN¥81.08 Million | CN¥537.59 Million | ▼ -21.0% |
| 2010 | 0.30x | CN¥147.36 Million | CN¥61.79 Million | CN¥491.74 Million | ▲ +11.5% |
| 2009 | 0.27x | CN¥103.42 Million | CN¥61.27 Million | CN¥384.68 Million | ▲ +23.6% |
| 2008 | 0.22x | CN¥83.90 Million | CN¥46.50 Million | CN¥385.66 Million | ▲ +6.8% |
| 2007 | 0.20x | CN¥90.51 Million | CN¥48.55 Million | CN¥444.39 Million | ▲ +15.9% |
| 2006 | 0.18x | CN¥67.08 Million | CN¥30.99 Million | CN¥381.63 Million | ▲ +53.7% |
| 2005 | 0.11x | CN¥40.83 Million | CN¥8.84 Million | CN¥357.12 Million | — |